-
Edasalonexent May Limit Disease Progression in Boys with Duchenne MD, Phase 1/2 Trial Shows
Investigational treatment edasalonexent blocked a crucial muscle disease protein in boys with Duchenne muscular dystrophy, according early trial results. Read more about these findings here.
What do you think of this news?
Sorry, there were no replies found.
Log in to reply.